
Pulse Biosciences, Inc: updates and filings
Price
$45.55
November 20, 2026Market cap $3.4B
What Ploutos Investor adds for Pulse Biosciences
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from 2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 5, 2026next Feb 5, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
September 2026
August 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 6, 2026Other material eventsForm8-K
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Results of operationsForm8-K
- Oct 14, 2026Other material eventsForm8-K
- Oct 7, 2026Other material eventsForm8-K
- Sep 15, 2026Material agreement entered, material agreement endedForm8-K
- Sep 15, 2026Other material eventsForm8-K
- Aug 6, 2026Material agreement enteredForm8-K
- Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Results of operationsForm8-K
- Jul 29, 2026Other material eventsForm8-K
- Jun 12, 2026Shareholder voteForm8-K
- Jun 10, 2026Other material eventsForm8-K
- May 14, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 13, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- May 11, 2026Annual meeting proxy statementFormDEF 14A
- May 6, 2026Other material eventsForm8-K
- May 4, 2026Results of operations, other material eventsForm8-K
- Apr 30, 2026Annual report (amendment)for the period to Dec 31, 2025Form10-K/A
- Apr 27, 2026Regulation FD disclosureForm8-K
- Apr 16, 2026Regulation FD disclosureForm8-K
- Apr 9, 2026Officer or director change, Regulation FD disclosureForm8-K
- Apr 7, 2026Other material eventsForm8-K
- Mar 27, 2026Officer or director changeForm8-K
- Mar 17, 2026Other material eventsForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 6, 2026 | 8-K | Other material events | Document |
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Results of operations | Document |
| Oct 14, 2026 | 8-K | Other material events | Document |
| Oct 7, 2026 | 8-K | Other material events | Document |
| Sep 15, 2026 | 8-K | Material agreement entered, material agreement ended | Document |
| Sep 15, 2026 | 8-K | Other material events | Document |
| Aug 6, 2026 | 8-K | Material agreement entered | Document |
| Aug 6, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | 8-K | Results of operations | Document |
| Jul 29, 2026 | 8-K | Other material events | Document |
| Jun 12, 2026 | 8-K | Shareholder vote | Document |
| Jun 10, 2026 | 8-K | Other material events | Document |
| May 14, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 13, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| May 11, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| May 6, 2026 | 8-K | Other material events | Document |
| May 4, 2026 | 8-K | Results of operations, other material events | Document |
| Apr 30, 2026 | 10-K/A | Annual report (amendment)for the period to Dec 31, 2025 | Document |
| Apr 27, 2026 | 8-K | Regulation FD disclosure | Document |
| Apr 16, 2026 | 8-K | Regulation FD disclosure | Document |
| Apr 9, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Apr 7, 2026 | 8-K | Other material events | Document |
| Mar 27, 2026 | 8-K | Officer or director change | Document |
| Mar 17, 2026 | 8-K | Other material events | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Nov 13, 2014.
The full analysis
What do Pulse Biosciences's filings show?
The filings are where every one of Pulse Biosciences's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.